AEGiS-Reuters: Researchers target how AIDS virus infects cells

Reuters, Ltd.Important note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
Click here to return to Reuters main menu


DonateNow


Researchers target how AIDS virus infects cells

Reuters NewMedia, Inc. - Thursday, 14 November 1996.


LONDON (Reuter) - Two teams of U.S. researchers said Wednesday they had found another clue on how the HIV virus tricks a body's immune system cells into opening themselves up to infection.

It uses one receptor on the cell as a sort of handle to attach itself. This then reveals a second handle that lets it take a firm hold on its victim, the two separate reports in the science journal Nature said.

The HIV virus infects cells by first hooking up to them, then injecting genetic material that forces the cell to make copies of the virus.

Scientists know where HIV attaches. Two receptors are involved -- the CD4 receptor and the CCR-5 receptor.

The CD4 receptor is meant for CD4 T-cells, the "helper" cells of the immune system, while the CCR-5 receptor is designed for chemokines -- chemicals used by cells to signal when they are in distress. But HIV circumvents the immune system by attaching to these receptors itself.

What scientists did not know was which was more important to HIV -- CD4 or CCR-5.

The two studies, published in the science journal Nature, show that CD4 makes it easier for a protein on the surface of the virus, gp-120, to hook up with the CCR-5 receptor.

"The virus is trying to get through the cell membrane," said Joseph Sodroski of the Dana-Farber Cancer Institute in Boston, Mass., who helped write one of the reports.

"It first has to attach to the cell and it then has to bring its envelope proteins closer to the cell membrane. CD4 sticks out like a stalk. CCR-5 is actually embedded in the membrane."

The CD4 receptor, he said, is "probably this rather flexible thing that binds the virus and then bends over and brings the virus down to CCR-5."

Their findings, they said, should help in designing drugs to battle HIV, and perhaps aid efforts to find a vaccine.

John Moore and colleagues at New York's Rockefeller University made a similar discovery.

Moore said the two-step process helped HIV protect itself from immune system attack.

"The virus wants to preserve its vulnerable sites from immune reaction, so it hides them as long as possible. They are exposed only transiently, until the virus hooks up to CCR-5."
961114
RE961148


Copyright © 1996 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.   Contact Reuters.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .